JPS59132889A - Preparation of l-alanine dehydrogenase - Google Patents
Preparation of l-alanine dehydrogenaseInfo
- Publication number
- JPS59132889A JPS59132889A JP58006338A JP633883A JPS59132889A JP S59132889 A JPS59132889 A JP S59132889A JP 58006338 A JP58006338 A JP 58006338A JP 633883 A JP633883 A JP 633883A JP S59132889 A JPS59132889 A JP S59132889A
- Authority
- JP
- Japan
- Prior art keywords
- streptomyces
- alanine
- alanine dehydrogenase
- producing
- mono
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010031025 Alanine Dehydrogenase Proteins 0.000 title claims abstract description 11
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims abstract description 35
- 241000187747 Streptomyces Species 0.000 claims abstract description 24
- 102000035195 Peptidases Human genes 0.000 claims abstract description 11
- 108091005804 Peptidases Proteins 0.000 claims abstract description 11
- 229950010030 dl-alanine Drugs 0.000 claims abstract description 11
- 235000019833 protease Nutrition 0.000 claims abstract description 11
- 239000002738 chelating agent Substances 0.000 claims abstract description 7
- 241000894006 Bacteria Species 0.000 claims abstract description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052751 metal Inorganic materials 0.000 claims abstract description 6
- 239000002184 metal Substances 0.000 claims abstract description 6
- 229960003767 alanine Drugs 0.000 claims description 17
- 241000187411 Streptomyces phaeochromogenes Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241000521327 Streptomyces caespitosus Species 0.000 claims description 2
- 241000187432 Streptomyces coelicolor Species 0.000 claims description 2
- 241000187392 Streptomyces griseus Species 0.000 claims description 2
- 241000187213 Streptomyces limosus Species 0.000 claims description 2
- 241000933146 Streptomyces roseus Species 0.000 claims description 2
- 241001646644 Streptomyces ruber Species 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 abstract description 2
- 241001147849 Streptomyces griseoluteus Species 0.000 abstract description 2
- 241000187391 Streptomyces hygroscopicus Species 0.000 abstract 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 abstract 1
- 229960001484 edetic acid Drugs 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 25
- 108090000790 Enzymes Proteins 0.000 description 25
- 230000000694 effects Effects 0.000 description 19
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 13
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 229950006238 nadide Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 101000823183 Alcaligenes faecalis Aralkylamine dehydrogenase heavy chain Proteins 0.000 description 2
- 101000823182 Alcaligenes faecalis Aralkylamine dehydrogenase light chain Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000187419 Streptomyces rimosus Species 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 241000205062 Halobacterium Species 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000187433 Streptomyces clavuligerus Species 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はストレプトミセス属に属するし一アラニンデヒ
ドロゲナーゼ(L−Alanine dehydrog
en−ase (EC’1.4.1.1) 、以下A
NDHという)生産能を有する菌株をDL−アラニンを
含む培地に培養し、得られた培養物からAβDHを採取
することを特徴とするAJDHの製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to L-alanine dehydrogenase (L-alanine dehydrogenase) belonging to the genus Streptomyces.
en-ase (EC'1.4.1.1), hereinafter A
The present invention relates to a method for producing AJDH, which comprises culturing a strain capable of producing AJDH (referred to as NDH) in a medium containing DL-alanine, and collecting AβDH from the resulting culture.
AβDHは、L−アラニン+NAD” + ’H20!
ピルビン酸十NH3++ NADH+ H+の反応を触
媒しL−アラニンの定量あるいはL−アラニンを含有す
るペプチドを基質とし種々のペプチダーゼを作用させ、
それより遊離するし一アラニンをAβDHで測定するこ
とによるペプチダーゼの活性測定法に利用される酵素と
して重要である。さらに、近年にはピルビン酸、アンモ
ニウム塩、NADHの存在下本酵素を作用せしめL−ア
ラニンを合成するなどの酵素反応器に使用する酵素とし
て注目されている。AβDH is L-alanine + NAD" + 'H20!
Catalyze the reaction of pyruvate, NH3++ NADH+ H+, quantify L-alanine, or act with various peptidases using a peptide containing L-alanine as a substrate.
It is important as an enzyme used in a method for measuring peptidase activity by measuring monoalanine released from it using AβDH. Furthermore, in recent years, this enzyme has been attracting attention as an enzyme used in enzyme reactors such as the synthesis of L-alanine by acting on this enzyme in the presence of pyruvic acid, ammonium salts, and NADH.
従来AβDHの生産菌としてはバチルス・セレウス〔ジ
ャーナル オブ バクテリオロジー(J。Conventional AβDH producing bacteria include Bacillus cereus [Journal of Bacteriology (J.
Bacteriol、) 76巻、578頁、 195
8年〕、バチルス・ズブチリス〔バイオキミカ エ バ
イオフィジカアクタ (Biochim、 Bioph
ys、 Acta) 96巻、248頁、 1965年
) 、バチルス・スファエリカス〔ヨーロピアン ジャ
ーナル オブ バイオケミストリー(Eur、J、 B
iocheIll、 ) 100巻、29頁、 1
979年〕、サーマス・サーモフィラス〔バイオキミカ
エバイオフィジカ アクタ(BiochiIIl、
Biophys。Bacteriol, ) vol. 76, p. 578, 195
8th year], Bacillus subtilis [Biochim, Bioph
ys, Acta) Vol. 96, p. 248, 1965), Bacillus sphaericus [European Journal of Biochemistry (Eur, J. B.
iocheIll, ) Volume 100, Page 29, 1
979], Thermus thermophilus [Biochimica Ebiophysica Acta (BiochiIIIl,
Biophys.
^cta) 615巻、34頁、 1980年〕、ハロ
バクテリウム・サリナリイウム〔同誌570巻、1頁、
1979年〕、ストレプトミセス・クラブリゲルス〔
アーカイフ゛ス オフ゛ マイクロバイオロジー(Ar
ch、 Mic−robiol、 ) 125巻、13
7頁、 1980年〕が知られている。上記菌株よりA
j! D Hを取得するには通常の炭素源、窒素源、
無機塩に誘導物質としてD−アラニンまたはL−アラニ
ンを添加した培地に培養する 。^cta) Vol. 615, p. 34, 1980], Halobacterium salinariium [Vol. 570, p. 1 of the same magazine,
1979], Streptomyces clavuligerus [
Archives Office Microbiology (Ar
ch, Mic-robiol, ) vol. 125, 13
7, 1980] is known. A from the above strains
j! To obtain DH, conventional carbon sources, nitrogen sources,
The cells are cultured in a medium containing an inorganic salt and D-alanine or L-alanine added as an inducer.
方法が行われているが、AβDHの生産性、価格などの
点から十分満足できるものではなかった。Although this method has been used, it has not been fully satisfactory in terms of AβDH productivity, price, etc.
本発明者らはAβDHを生産する菌株を検索しその製造
法について検討を重ねたところ、ストレプトミセス属に
属する菌株を、誘導物質としてDL−アラニンを含む培
地に培養するとAβDHが著量蓄積されることを見いだ
した。DL−アラニンはし一アラニンまたはD−アラニ
ンに比較して極めて安価であり、その産業的価値は大き
なものがある。The present inventors searched for strains that produce AβDH and repeatedly studied methods for producing them, and found that when a strain belonging to the genus Streptomyces is cultured in a medium containing DL-alanine as an inducer, AβDH accumulates in large amounts. I found out. DL-alanine is extremely inexpensive compared to monoalanine or D-alanine, and has great industrial value.
さらに、本発明者らは得られた培養物からjlDHを精
製するに当たってエチレンジアミン四酢酸(以下II!
DTAという)な8の金属キレート剤を使用することに
より混在するペプチダーゼが容易に除去されることを知
り、その結果Aj!DHを高収率で得ることに成功した
。ペプチダーゼは、AJDHをペプチダーゼ活性測定用
酵素の一つとして使用する場合には混在してはならない
ものとされている。Furthermore, the present inventors purified jlDH from the obtained culture using ethylenediaminetetraacetic acid (hereinafter referred to as II!).
It was discovered that mixed peptidases can be easily removed by using a metal chelating agent (called DTA), and as a result, Aj! We succeeded in obtaining DH in high yield. Peptidase must not be mixed when AJDH is used as one of the enzymes for measuring peptidase activity.
本発明で使用されるストレプトミセス属に属する菌株と
はストレプトミセス・グリセオルテラス(Strept
omyces griseoluteus ) 、スト
レプトミセス・ヒゲロスコピカス(S、 hygros
copicus) 、。The strain belonging to the genus Streptomyces used in the present invention is Streptomyces griseortelus (Streptomyces griseortelus).
omyces griseoluteus), Streptomyces hygeloscopicus (S, hygros)
copicus),.
ストレプトミセス・アルボロンゲス(S、 albol
o−ngus) 、ストレプトミセス・リモサス(S、
rimo−SUS ) 、ストレプトミセス・ファエ
オクロモゲネス(S、 phaeochromogen
es ) 、ストレプトミセス・リディカス(S、 I
ydicus) 、ストレプトミセス・カエスピトサス
(S、 caespi tosus) %ストレプトミ
セス・コエリコロル(S、 coeLicolor )
、ストレプトミセス・ロゼウス(S、 roseus
) 、ストレプトミセス・アルプス(S、 albu
s) 、ストレプトミセス・オリボクロモゲネス(3,
01ivochro−mogenes )−、ストレプ
トミセス・ルベル(S、 ru−ber ) 、ストレ
プトミセス・グリセウス(S、 gr−iseus )
またはストレプトミセス・メラノスポレア(S、 me
lanosporea )などである。これらのうち特
に好ましいのはストレプトミセス・グリセオルテラス(
S、 griseoluteus ) IAM 006
0、ストレプトミセス・ヒゲロスコピカス(S、 hy
groscopi−cus ) IFO3934、スト
レプトミセス・リモサス(S、 rimosus) I
FO3226またはストレプトミセス・ファエオクロモ
ゲネス(S、 phaeochromogenes )
IFO3149である。Streptomyces albolonges (S, albol)
ongus), Streptomyces limosus (S,
rimo-SUS), Streptomyces phaeochromogenes (S, phaeochromogen)
es), Streptomyces ridicus (S, I
ydicus), Streptomyces caespitosus (S, caespitosus) % Streptomyces coelicolor (S, coeLicolor)
, Streptomyces roseus (S, roseus
), Streptomyces alpus (S, albu
s), Streptomyces oligochromogenes (3,
01ivochro-mogenes)-, Streptomyces ruber (S, ru-ber), Streptomyces griseus (S, gr-iseus)
or Streptomyces melanosporea (S, me
lanosporea). Among these, Streptomyces griseolterus (
S. griseoluteus ) IAM 006
0, Streptomyces hygeloscopicus (S, hy
groscopei-cus) IFO3934, Streptomyces rimosus (S, rimosus) I
FO3226 or Streptomyces phaeochromogenes (S, phaeochromogenes)
It is IFO3149.
上記菌株をDL−アラニンを含む培地に培養し、従来知
られているバチルス・スファエリカス菌との/IDHI
D性の比較を行った。(第1表)第1表
第1表から、本発明法の有用性がわかる。The above strain was cultured in a medium containing DL-alanine, and /IDHI with the conventionally known Bacillus sphaericus bacteria was obtained.
D properties were compared. (Table 1) Table 1 From Table 1, the usefulness of the method of the present invention can be seen.
本発明法において使用される培地としては種々の炭素源
、窒素源、無機塩ならびにDL−アラニンを含む培地で
あれば合成培地、天然培地いずれでも用いることができ
る。培養形態は固体培養、液体培養のいずれでもよいが
、本酵素は菌体内酵素であるから集菌に便利な液体培養
が好ましい。As the medium used in the method of the present invention, either a synthetic medium or a natural medium can be used as long as it contains various carbon sources, nitrogen sources, inorganic salts, and DL-alanine. The culture form may be either solid culture or liquid culture, but since the present enzyme is an intracellular enzyme, liquid culture is preferred because it is convenient for bacterial collection.
DL−アラニンの培地への添加量は0.1〜10%であ
り、より好ましくは0.5〜2%である。ストレプトミ
セス・ファエオクロモゲネスIP03149株を麦芽エ
キス、酵母エキスおよび無機塩からなる栄養培地に培養
したときのoL−アラニン添加の効果を第2表に示す。The amount of DL-alanine added to the medium is 0.1 to 10%, more preferably 0.5 to 2%. Table 2 shows the effect of adding oL-alanine when Streptomyces phaeochromogenes strain IP03149 was cultured in a nutrient medium consisting of malt extract, yeast extract, and inorganic salts.
第2表
本発明において用いられる菌株の培養条件について述べ
ると、培養温度は菌が生育し/IDHが生産される範囲
内であればいずれの温度でもよいが、好ましくは25〜
35℃である。puは通常6〜8の範囲で行われる。培
養時間は酵素力価が最高に達する時間を選べばよく、通
常24〜48時間である。Table 2 Describing the culture conditions for the bacterial strain used in the present invention, the culture temperature may be any temperature within the range where the bacteria can grow/IDH can be produced, but preferably 25 to
The temperature is 35°C. pu is usually carried out in the range of 6-8. The culture time may be selected so that the enzyme titer reaches its maximum, and is usually 24 to 48 hours.
以上のようにして得られた培養物からA11DHを採取
するには、本酵素が菌体内に存在するためまず菌体の破
砕を行う。すなわち、培養物をそのまま、好ましくはろ
過または遠心分離により菌体のみを集め超音波、アルミ
ナ磨砕などの機械的方法によって菌体を破砕する。その
後、ろ過もしくは遠心分離によって固形物を除き粗酵素
液を得、さらに本酵素液を塩析、有機溶媒沈澱、吸着ク
ロマトグラフィー、イオン交換クロマトグラフィー、ゲ
ルろ過などの公知の精製方法を適宜組合せることにより
精製AJDH標品が得られる。In order to collect A11DH from the culture obtained as described above, the bacterial cells are first disrupted since this enzyme exists within the bacterial cells. That is, only the bacterial cells are collected from the culture as is, preferably by filtration or centrifugation, and the bacterial cells are disrupted by a mechanical method such as ultrasonication or alumina grinding. Thereafter, solid matter is removed by filtration or centrifugation to obtain a crude enzyme solution, and the enzyme solution is further subjected to appropriate combinations of known purification methods such as salting out, organic solvent precipitation, adsorption chromatography, ion exchange chromatography, and gel filtration. A purified AJDH specimen is thereby obtained.
ここで、前記したように本発明者らは精製の一手段とし
て金属キレート剤を用いると混在するペプチダーゼが容
易に除去されることを知った。金属キレート剤としては
EDTA 、α、α゛−ジピリジル、0−フェナンスロ
リンなどが例示され、使用に当たっては精製段階の任意
の点において酵素溶液に添加するだけでよい。添加濃度
は0.1〜101であり、より好ましくは0.5〜2m
Mである。Here, as described above, the present inventors found that by using a metal chelating agent as a means of purification, contaminating peptidases can be easily removed. Examples of the metal chelating agent include EDTA, α, α-dipyridyl, and 0-phenanthroline, which need only be added to the enzyme solution at any point during the purification step. Addition concentration is 0.1-101, more preferably 0.5-2m
It is M.
ストレプトミセス・ファエオクロモゲネスlPO314
9株の培養菌体を、1mM RDTAを含む20mM
)リス塩酸緩衝液に懸濁しセルミル(エドムント・ヴユ
ラー社製)にて破砕することにより粗酵素抽出液を得た
。この液に硫酸アンモニウムを50%飽和になるように
加えてAl1Df(を沈澱させ、沈澱を上記と同じ緩衝
液に溶解したのちセファデックスG−25(ファルマシ
ア社製)でゲルろ過、次いでDBAE−セルロース(ブ
ラウン社りカラムクロマトグラフィーを行い、各段階の
、M!DH活性およびペプチダーゼ活性を測定した。E
DTAを加えないで、他は上記と同様に操作した場合と
の比較を第3表に示す。なおペプチダーゼ活性の測定は
公知のロイシンアミノペプチダーゼ測定用試薬であるL
APC−テストワコー(和光純薬社製)を使用した。Streptomyces phaeochromogenes lPO314
Cultured bacterial cells of 9 strains were mixed with 20mM containing 1mM RDTA.
) A crude enzyme extract was obtained by suspending the enzyme in Lis-HCl buffer and crushing it with Cellmil (manufactured by Edmund Vuiller). Add ammonium sulfate to this solution to 50% saturation to precipitate Al1Df, dissolve the precipitate in the same buffer as above, gel filtrate with Sephadex G-25 (manufactured by Pharmacia), and then DBAE-cellulose ( Braun Co. column chromatography was performed to measure M!DH activity and peptidase activity at each stage.
Table 3 shows a comparison with the case where the same procedure as above was performed without adding DTA. The peptidase activity was measured using L, a known reagent for measuring leucine aminopeptidase.
APC-Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.) was used.
第3表
第3表に示す通り EDTAを添加することにより容易
にペプチダーゼが除去されることがわかる。As shown in Table 3, it can be seen that peptidase is easily removed by adding EDTA.
無添加の場合はさらに複雑な精製工程が必要となる。If no additive is used, a more complicated purification process is required.
上記方法により極めて低廉な培地原料を使用して著量の
Aj!DHを蓄積せしめることができ、かつ簡単な操作
によりペプチダーゼを含まないAβDHが収率よく得ら
れた。By using the above method, a significant amount of Aj! can be obtained using extremely inexpensive medium raw materials! DH could be accumulated and peptidase-free AβDH could be obtained in good yield through simple operations.
次ぎに以上のようにして得られたAβDHの活性測定法
および理化学的性質について述べる。Next, a method for measuring the activity and physicochemical properties of AβDH obtained as described above will be described.
AβDHの酵素活性はL−アラニンとニコチンアミドア
デニンジヌクレオチド(以下NAD+という)を基質と
して酵素を反応させ、生成するNAD!(を340nm
における吸光度の増加から測定することにより算出され
る。すなわち、0.1Mグリシン−NaOH緩衝液(p
H10,0) 0.87me、21mM NAD” 0
.05me、0.5 M L−アラニン0.06−およ
び酵素溶液0.02−を混合し25℃で反応させ、反応
開始後1分間の340nmにおける吸光度の増加を測定
する。対照としてL−アラニン溶液の代わりに水を用い
て上記と同様に操作し、得られた吸光度をブランク値と
して上記測定値から差引き、その値から生成NADHの
量を求める。酵素活性の表示は1分間に1μモルのNA
DHを生成する酵素量を1単位とした。The enzymatic activity of AβDH is produced by reacting the enzyme with L-alanine and nicotinamide adenine dinucleotide (hereinafter referred to as NAD+) as substrates. (340nm
It is calculated by measuring the increase in absorbance at . That is, 0.1M glycine-NaOH buffer (p
H10,0) 0.87me, 21mM NAD" 0
.. 05me, 0.5M L-alanine 0.06- and enzyme solution 0.02- are mixed and reacted at 25°C, and the increase in absorbance at 340 nm for 1 minute after the start of the reaction is measured. As a control, operate in the same manner as above using water instead of the L-alanine solution, and subtract the obtained absorbance from the above measured value as a blank value, and determine the amount of produced NADH from that value. Enzyme activity is expressed as 1 μmol NA per minute.
The amount of enzyme that produces DH was defined as 1 unit.
ストレプトミセス・ファエオクロモゲネス lPO31
49株より得られたAβD Hの理化学的性質は次のと
おりである。Streptomyces phaeochromogenes lPO31
The physicochemical properties of AβDH obtained from 49 strains are as follows.
Tl) 作用 本酵素は次式に示す反応を触媒する。Tl) Effect This enzyme catalyzes the reaction shown in the following formula.
L−アラニン十NAD++ H20
4ピルビン酸十NH3” + NADH+ H”(2)
基質特異性
本酵素は第4表に示すように、L−アラニン以外のし一
アミノ酸にはほとんどもしくは全く作用しない。D−ア
ラニンを始めとするD−アミノ酸には作用しない。補酵
素としてNADP+を用いた場合はNAD+に比較し約
0.6%の活性を示すのみである。L-alanine ten NAD++ H20 4 pyruvate ten NH3” + NADH+ H” (2)
Substrate specificity As shown in Table 4, this enzyme has little or no effect on amino acids other than L-alanine. It does not act on D-amino acids including D-alanine. When NADP+ is used as a coenzyme, it exhibits only about 0.6% activity compared to NAD+.
第4表
(3)至適pH
pH7〜11の各p++において25℃、1分間反応し
たところ、pi(10付近が至適であった。Table 4 (3) Optimal pH When the reaction was carried out at 25° C. for 1 minute at each p++ of pH 7 to 11, the optimum value was pi (around 10).
(第1図)
(41pH安定性
pH4〜11の各pHにおいて25°C13時間処理し
たのちの残存活性を測定したところ、p)l 7〜9の
、 範囲で安定であった。(第2図)(5)至適温度
20〜60℃の各温度においてpi(10,0,1分間
反応したところ、60℃付近における活性が最大であっ
た。(第3図)
(6) 熱安定性
0〜65℃の各温度においてpH7,0,20分間処理
したのちの残存活性を測定したところ、45℃以下で安
定であ、った。(第4図)
(7) 阻害剤および活性化剤
第5表に示す各種薬剤を加え活性を測定したところ、本
酵素はCu”、Pb2+の金属イオンおよびPCMB
(パラクロロマーキュリ安息香酸)のごときSH阻害剤
によって活性が阻害された。またEoriなどの金属キ
レート剤およびジチオスライトールなどのS■保護試薬
によって活性化を受ける。(Figure 1) (41 pH Stability When the residual activity was measured after treatment at 25°C for 13 hours at each pH of 4 to 11, it was found to be stable in the range of p)l 7 to 9. (Fig. 2) (5) Optimum Temperature When pi (10, 0, and 1 minute reaction was performed at each temperature of 20 to 60°C, the activity was maximum at around 60°C. (Fig. 3) (6) Thermal stability When the residual activity was measured at pH 7, 0 and 20 minutes at various temperatures from 0 to 65°C, it was found to be stable below 45°C. (Figure 4) (7) Inhibitor and When various agents listed in Table 5 were added as activators and the activity was measured, this enzyme was found to be activating Cu'', Pb2+ metal ions and PCMB.
The activity was inhibited by SH inhibitors such as (parachloromercuribenzoic acid). It is also activated by metal chelating agents such as Eori and S■ protecting reagents such as dithiothreitol.
(以下余白)
第5表
(8)基質親和性
本酵素のし一アラニン、NAD+に対するミバエリス定
数(Km値)はpH10,0,25℃の条件において、
それぞれ?、IX 10−3 M、 3.6X 10−
5 Mであった。(Margins below) Table 5 (8) Substrate affinity The Miberellis constant (Km value) for this enzyme, alanine, and NAD+ at pH 10, 0, and 25°C.
Each? , IX 10-3 M, 3.6X 10-
It was 5M.
(9)分子量
セファデックスG−200によるゲルろ適法では、分子
量約240,000、また5O5−ディスクゲル電気泳
動法による結果からは分子量約39.000の単一のサ
ブユニットから構成されていることがわかった。(9) Molecular weight: According to the gel filtration method using Sephadex G-200, the molecular weight is approximately 240,000, and from the results of 5O5-disk gel electrophoresis, it is composed of a single subunit with a molecular weight of approximately 39,000. I understand.
実施例1
麦芽エキス0.3%、酵母エキス0.2%、DL−アラ
ニン1%、KH2PO40,1%、MCI 0.05%
、MgSO4・7H200,05%、FeSO4・7H
200,001%(pH7,2)から成る組成の培地1
00m1!を入れた500m容の坂ロフラスコにストレ
プトミセス・リモサス IFo 3226株を一白金耳
接種し、30℃で48時間振盪培養し種培養液とした。Example 1 Malt extract 0.3%, yeast extract 0.2%, DL-alanine 1%, KH2PO40.1%, MCI 0.05%
, MgSO4・7H200,05%, FeSO4・7H
Medium 1 with a composition of 200,001% (pH 7.2)
00m1! One platinum loop of Streptomyces rimosus IFo 3226 strain was inoculated into a 500 m capacity Sakalo flask containing 500 m of the flask, and cultured with shaking at 30°C for 48 hours to obtain a seed culture solution.
次ぎに、上記と同じ組成の培地2000−を入れた30
0〇−容のジャーファーメンタ−に種培養液40−を接
種し、30℃、48時間通気攪拌培養した。培養液を遠
心分離して菌体を集め1 mM EDTAを含む20m
M )リス塩酸緩衝液(pH7,0)に懸濁後、セルミ
ルにて10分間菌体破砕を行った。この菌体抽出液を遠
心分離して固形物を除去し得られた上清液に硫酸アンモ
ニウムを50%飽和になるように加えAβDHを沈澱さ
せた。沈澱を遠心分離により集め、上記同緩衝液に溶解
したのちセファデックスG−25を使用したゲルろ過に
より脱塩した。得られた酵素液を同緩衝液(pH7,5
)で平衡化したDEAE−セルロースカラムに吸着させ
、0.4)I KCIを含む同緩衝液(pH7,5)で
溶出した。酵素活性を含む溶出画分を集め限外ろ過によ
り濃縮したのち、同緩衝液(pH7,0)を外液として
透析した。透析液を同緩衝液(pH7,0)で平衡化し
たブルーセファロースカラムに吸着させ、0.3 M
MCIを含む同緩衝液(pH7,0)でAADHを溶出
した。活性画分を集め、限外ろ過により濃縮、脱塩した
のち凍結乾燥し、比活性5.Ou/mgのAj2DH粉
末が260mg得られた。Next, 300ml of medium 2000-ml with the same composition as above was added.
The seed culture solution was inoculated into a 00-volume Jar Fermentor and cultured with aeration at 30°C for 48 hours. Centrifuge the culture solution to collect the bacterial cells and add 20mM containing 1mM EDTA.
M) After suspending in Lis-HCl buffer (pH 7.0), the cells were disrupted for 10 minutes using a cell mill. This bacterial cell extract was centrifuged to remove solid matter, and ammonium sulfate was added to the resulting supernatant to 50% saturation to precipitate AβDH. The precipitate was collected by centrifugation, dissolved in the same buffer, and then desalted by gel filtration using Sephadex G-25. The obtained enzyme solution was diluted with the same buffer solution (pH 7.5
) and eluted with the same buffer (pH 7.5) containing 0.4) I KCI. The eluate fractions containing enzyme activity were collected and concentrated by ultrafiltration, and then dialyzed using the same buffer (pH 7.0) as an external solution. The dialysate was adsorbed onto a blue Sepharose column equilibrated with the same buffer (pH 7,0), and 0.3 M
AADH was eluted with the same buffer (pH 7.0) containing MCI. The active fractions were collected, concentrated by ultrafiltration, desalted, and then lyophilized to a specific activity of 5. 260 mg of Aj2DH powder of Ou/mg was obtained.
実施例2
ストレプトミセス・ファエオクロモゲネスlPO314
9株を使用して、実施例1と同様に操作し、比活性6.
5 u/ mgのA#DH粉末155mgを得た。Example 2 Streptomyces phaeochromogenes lPO314
9 strains were operated in the same manner as in Example 1, and the specific activity was 6.
155 mg of 5 u/mg A#DH powder was obtained.
第1図は本発明法によりストレプトミセス・ファエオク
ロモゲネス IPo 3149株から得られたAADH
の至適pHを表す図であり、第2図は同じ< pH安
定性、第3図は至適温度、第4図は熱安定性を表す図で
ある。
特許出願−人 天野製薬株式会社
第 1 図
pH
第 2 メ
3 5 7 9 1
1pl+
第 3 図
20 30 4150 60−4】 度
(0C)
第 4 図
温 度 (0c)Figure 1 shows AADH obtained from Streptomyces phaeochromogenes IPo 3149 strain by the method of the present invention.
FIG. 2 is a diagram showing the optimum pH stability, FIG. 3 is a diagram showing the optimum temperature, and FIG. 4 is a diagram showing thermal stability. Patent application - Person Amano Pharmaceutical Co., Ltd. Figure 1 pH Figure 2 Me 3 5 7 9 1
1pl+ Figure 3 20 30 4150 60-4 Degrees (0C) Figure 4 Temperature (0c)
Claims (1)
ロゲナーゼ生産菌をDL−アラニンを含む培地に培養し
培養物からし一アラニンデヒドロゲナーゼを採取するこ
とを特徴とするし一アラニンデヒドロゲナーゼの製造法
。 (2) ストレプトミセス属に属するL−アラニンデ
ヒドロゲナーゼ生産菌がストレプトミセス・グリセオル
テラス、ストレプトミセス・ヒゲロスコピカス、ストレ
プトミセス・アルボロンゲス、ストレプトミセス・リモ
サス、ストレプトミセス・ファエオクロモゲネス、スト
レプトミセス・リディカス、ストレプトミセス・カエス
ピトサス、ストレプトミセス・コエリコロル、ストレプ
トミセス・ロゼウス、ストレプトミセス・アルプス、ス
トレプトミセス・オリポクロモゲネス、ストレプトミセ
ス・ルベル、ストレプトミセス・グリセウスまたはスト
レプトミセス・メラノスポレアである特許請求の範囲第
1項記載のL−アラニンデヒドロゲナーゼの製造法。 +3) DL−アラニンの培地への添加量が0.1〜
10%である特許請求の範囲第1項記載のし一アラニン
デヒドロゲナーゼの製造法。 (4) 培養物からし一アラニンデヒドロゲナーゼを
採取するに際し金属キレート剤を使用して混在するペプ
チダーゼを除去する操作を含むことを特徴とする特許請
求の範囲第1項記載のし一アラニンデヒドロゲナーゼの
製造法。 (5) 金JfEキレート剤がエチレンジアミン四酢
酸、α、α9−ジピリジルまたは0−フェナンスロリン
である特許請求の範囲第4項記載のL−アラニンデヒド
ロゲナーゼの製造法。[Claims] (11) Production of mono-alanine dehydrogenase, which is characterized by culturing mono-alanine dehydrogenase-producing bacteria belonging to the genus Streptomyces in a medium containing DL-alanine, and collecting mono-alanine dehydrogenase from the culture. (2) L-alanine dehydrogenase-producing bacteria belonging to the genus Streptomyces include Streptomyces griseoltellus, Streptomyces higeroscopicus, Streptomyces albolonges, Streptomyces limosus, Streptomyces phaeochromogenes, and Streptomyces spp. claims that are Streptomyces caespitosus, Streptomyces coelicolor, Streptomyces roseus, Streptomyces alpus, Streptomyces olipochromogenes, Streptomyces ruber, Streptomyces griseus or Streptomyces melanosporea The method for producing L-alanine dehydrogenase according to item 1. +3) The amount of DL-alanine added to the medium is 0.1 to
10% of the method for producing alanine dehydrogenase according to claim 1. (4) The production of mono-alanine dehydrogenase according to claim 1, which comprises an operation of removing mixed peptidase using a metal chelating agent when collecting the mono-alanine dehydrogenase from a culture. Law. (5) The method for producing L-alanine dehydrogenase according to claim 4, wherein the gold JfE chelating agent is ethylenediaminetetraacetic acid, α, α9-dipyridyl, or 0-phenanthroline.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58006338A JPS59132889A (en) | 1983-01-17 | 1983-01-17 | Preparation of l-alanine dehydrogenase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58006338A JPS59132889A (en) | 1983-01-17 | 1983-01-17 | Preparation of l-alanine dehydrogenase |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS59132889A true JPS59132889A (en) | 1984-07-31 |
Family
ID=11635576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58006338A Pending JPS59132889A (en) | 1983-01-17 | 1983-01-17 | Preparation of l-alanine dehydrogenase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59132889A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116748A (en) * | 1988-09-27 | 1992-05-26 | Toyo Jozo Kabushiki Kaisha | Process for the production of l-alanine dehydrogenase from 78-3 ferm bp-2517 |
-
1983
- 1983-01-17 JP JP58006338A patent/JPS59132889A/en active Pending
Non-Patent Citations (1)
Title |
---|
ACHIVES OF MICROBIOLOGY=1980 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116748A (en) * | 1988-09-27 | 1992-05-26 | Toyo Jozo Kabushiki Kaisha | Process for the production of l-alanine dehydrogenase from 78-3 ferm bp-2517 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Roon et al. | Glutamate synthase: properties of the reduced nicotinamide adenine dinucleotide-dependent enzyme from Saccharomyces cerevisiae | |
Roberts et al. | Isolation, crystallization, and properties of indolyl-3-alkane alpha-hydroxylase. A novel tryptophan-metabolizing enzyme. | |
US4590161A (en) | Microbiologically produced L-phenylalanine-dehydrogenase, process for its recovery and use | |
US20120149071A1 (en) | D-aminoacylase | |
JP3041840B2 (en) | Novel glycerol dehydrogenase, its production method and its use | |
JPH069504B2 (en) | Rhodococcus specs containing phenylalanine-dehydrogenase and method for obtaining the same | |
JPS59132889A (en) | Preparation of l-alanine dehydrogenase | |
US5116748A (en) | Process for the production of l-alanine dehydrogenase from 78-3 ferm bp-2517 | |
Kumagai et al. | A new D-aminoacylase from Defluvibacter sp. A 131-3 | |
JPS5915625B2 (en) | Novel acyl coenzyme A oxidase and its production method | |
EP0079792B1 (en) | Process for production of urease | |
JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
JPS63251082A (en) | Production of nadh oxidase | |
JP3156832B2 (en) | Ammonia measurement reagent composition | |
JP3102543B2 (en) | Glutamate dehydrogenase and method for producing the same | |
JP3040228B2 (en) | L-fucose dehydrogenase, method for producing the same, and method for quantifying L-fucose | |
JP3413294B2 (en) | Method for producing 2,5-dihydroxypyridine and bacteria producing 2,5-dihydroxypyridine | |
JPH0655137B2 (en) | L-phenylalanine dehydrogenase and method for producing the same | |
EP0643139A2 (en) | Process for preparing indigo | |
JP2680686B2 (en) | Method for producing putrescine: pyruvate transaminase | |
JPS6318471B2 (en) | ||
MATSUI et al. | Purification and properties of alanine dehydrogenase from Bacillus natto KMD 1126 | |
JPS62262989A (en) | Production of pyrroline-5-carboxylic acid dehydrogenase | |
JPH0146117B2 (en) | ||
JPH0630572B2 (en) | L-phenylalanine dehydrogenase |